BOARD / PERSPECTIVE

长期经验，
清晰判断。Long experience.
Clear judgment.

董事会的公开履历横跨资本市场治理与生物制药研发体系。The board's public track record spans capital-market governance and biopharma R&D.

Qi Gong

Qi Gong

CHAIRWOMAN

纳斯达克 Quartzsea（QSEA）董事长兼首席执行官、首席财务官；QuasarEdge（QRED）董事长兼首席执行官、首席财务官；Yotta（YOTA）、Quetta（QETA）、Quantumsphere（QUMS）独立董事。美国华尔街上市融资集团及美国信息科技创始人，合肥工业大学毕业，总统志愿服务奖得主。Chairwoman, CEO & CFO of Nasdaq-listed Quartzsea (QSEA); Chairwoman, CEO & CFO of QuasarEdge (QRED); independent director of Yotta (YOTA), Quetta (QETA) and Quantumsphere (QUMS). Founder of the American Wall Street Listed Group and American Information Technology Inc.; Hefei University of Technology graduate; recipient of the President's Volunteer Service Award.

Pen Lan

Pen Lan

DIRECTOR

董事会成员。完整履历将适时公布。Member of the board. Full bio to be announced.

Keejong Chang

Keejong Chang

DIRECTOR

可蓝赛生物医药（上海）董事长兼首席技术官；25年以上生物制药研发与产业化经验；加州大学河滨分校生物化学博士；3项美国专利、1项欧洲专利，发表学术论文29篇以上。Chairman & CTO of Keycell Lines Biopharmaceutical (Shanghai); 25+ years across drug discovery, biologics and cell/gene platforms; Ph.D. in Biochemistry, UC Riverside; inventor on 3 U.S. and 1 European patent; 29+ scientific publications.